Bottom line
Is RSPH a good fund? The bottom line
RSPH is an index health care sector ETF from Invesco.
It charges 0.4% — about $40 a year on every $10,000 invested, cheaper than 85% of health care sector funds we track.
It returned +9.3% over one year, +4.7% a year over five years, +8.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $767 million in net assets and 63 holdings, its largest position is Bio-Techne Corp. (2.1%) and the top 10 make up 19.4% of the portfolio.
What stands out
- Low cost: cheaper than 85% of health care sector peers
Updated Nov 19, 2026
What RSPH invests in
The Invesco S&P 500 Equal Weight Health Care ETF (the Fund) seeks to track the investment results (before fees and expenses) of the S&P 500 Equal Weight Health Care Index (the Underlying Index).
The Fund is an index fund that seeks to track the investment results of the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (S&P DJI or the Index Provider) compiles, maintains and calculates the Underlying Index, which is composed of securities of all companies included in the S&P 500 Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (GICS ). The health care sector includes health care providers and services, companies that manufacture and distribute health care equipment and supplies, health care technology companies and companies involved in the research, development, production and marketing of pharmaceuticals and biotechnology products. The Underlying Index is an equal-weighted index, which means that, unlike the S&P 500 Index, which…
From the fund's prospectus (filed Aug 27, 2026).
RSPH performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| RSPH | +9.3% | +4.7% | +8.2% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What RSPH costs
On a $10,000 investment, RSPH's 0.4% expense ratio costs about $40 a year. The prospectus estimates $505 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
RSPH top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Bio-Techne Corp. | 2.13% |
| 2 | IQVIA Holdings Inc. | 2.00% |
| 3 | Baxter International Inc. | 1.99% |
| 4 | Regeneron Pharmaceuticals, Inc. | 1.96% |
| 5 | Mettler-Toledo International Inc. | 1.94% |
| 6 | Charles River Laboratories International, Inc. | 1.93% |
| 7 | Veeva Systems Inc. | 1.93% |
| 8 | DaVita Inc. | 1.87% |
| 9 | Moderna, Inc. | 1.85% |
| 10 | Thermo Fisher Scientific Inc. | 1.84% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 19.4% of the fund. See all top 25 holdings and asset mix →